Adipose-derived stem cells conjugated with CD90/ICAM-1-tMBs, known as StemBells, have been proposed as an image-guided treatment for myocardial infarction (MI) [130] and to prevent atherosclerosis acceleration post-MI [131]. Here, ICAM1 is linked to myocardial infarction.